CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Amarin Pharmaceuticals Ireland's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 4, 2024Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy1
Apr 24, 2024Methods Of Reducing The Risk Of Cardiovascular Events In A Subject1
Aug 25, 2021Compositions And Methods For Lowering Levels Of High-Sensitivity (Hs-Crp) In A Subject2
Mar 10, 2021Compositions And Methods For Lowering Triglycerides Without Raising Ldl-C Levels In A Subject On Concomitant Statin Therapy3
Dec 9, 2020Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy3
Sep 9, 2020Stable Pharmaceutical Composition And Methods Of Using Same1
Nov 27, 2019Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia2
Nov 27, 2019Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia2

Top competitors of Amarin Pharmaceuticals Ireland

List of top competitors of Amarin Pharmaceuticals Ireland based on patent oppositions.